Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.4.2 was added. The funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check38 days agoChange DetectedAdded a site-wide notice about government funding lapse with links to cc.nih.gov and opm.gov. Updated page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check45 days agoChange DetectedThe page gains a glossary toggle and updated metadata, including 'Last Update Submitted that Met QC Criteria' and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 as the page revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now presents a single 'Locations' section listing Ohio and Pennsylvania, replacing the separate 'Ohio Locations' and 'Pennsylvania Locations' entries. The 'HHS Vulnerability Disclosure' footer link was removed and the page revision updated to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.